×
Zhongchao Price to Free Cash Flow Ratio 2019-2024 | ZCMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Zhongchao price to free cash flow ratio from 2019 to 2024. Price to free cash flow ratio can be defined as
View More
Zhongchao Price to Free Cash Flow Ratio 2019-2024 | ZCMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Zhongchao price to free cash flow ratio from 2019 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Tempus AI (TEM)
$8.5B
Inspire Medical Systems (INSP)
$5.3B
Hims & Hers Health (HIMS)
$5.1B
Privia Health (PRVA)
$2.5B
Enovis (ENOV)
$2.5B
IRhythm Technologies (IRTC)
$2.4B
Azenta (AZTA)
$2B
Omnicell (OMCL)
$2B
Clover Health Investments (CLOV)
$1.6B
10x Genomics (TXG)
$1.6B
Schrodinger (SDGR)
$1.4B
Phreesia (PHR)
$1.1B
Butterfly Network (BFLY)
$650M
Standard BioTools (LAB)
$562M
Talkspace (TALK)
$522M
Fulgent Genetics (FLGT)
$520M
Definitive Healthcare (DH)
$483M
Health Catalyst (HCAT)
$459M
TruBridge (TBRG)
$244M
Pulmonx (LUNG)
$237M
SOPHiA GENETICS SA (SOPH)
$214M
American Well (AMWL)
$122M
EUDA Health Holdings (EUDA)
$107M
P3 Health Partners (PIII)
$75M
HeartBeam (BEAT)
$67M
111 (YI)
$53M
CareCloud (CCLD)
$46M
Zepp Health (ZEPP)
$40M
SHL Telemedicine (SHLT)
$40M
Outset Medical (OM)
$39M